CARA Therapeutics

Cara possesses both near-term clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's first patented compound, CR665, has entered clinical testing for acute pain. This best-in-class compound possesses unique analgesic and anti-inflammatory activities appropriate for multiple therapeutic applications. In addition, Cara aims to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology.

Contact Details: 765 Old Saw Mill River Road Tarrytown New York 10591 United States of America Tel: 914 347-4040 Fax: 914 347-4442 Email: info@caratherapeutics.com WWW: www.caratherapeutics.com/

Loading...

Recent Publications by CARA Therapeutics:
The role of the intestine in drug metabolism and pharmacokinetics: an industry perspective. Over the past decade, our knowledge concerning the importance of...	7th December, 2007	Cara Therapeutics,	Curr Drug Metab. 2007 Oct;8(7):694-9.

CARA Therapeutics Clinical Trials:
Study to Evaluate Analgesic Effect of Intravenous Administration of Kappa Agonist CR845 After Hysterectomy Surgery

CARA Therapeutics Patents:
US Patent No.	Title
7517874	Substituted imidazo[1,5-a][1,4]diazepines and imidazo[1,5-a]pyrazines as cannabinoid receptor agonists for the treatment of pain
7504538	Amide or thioamide derivatives and their use in the treatment of pain
7402564	Synthetic peptide amides

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 423 times since April 2007, the link to the organisation's website has been followed 65 times

Search for more companies in Tarrytown

Search for more companies in New York

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for CARA Therapeutics